Recent Finacing
Recent Raise
CuraSen Therapeutics is a clinical-stage biotech developing small-molecule adrenergic receptor-targeting therapies, including CST-3056 α1A-AR and β2-AR agonists with β-blocker combinations, for neurodegenerative diseases.
